Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Related Posts
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a…
Research Finds Vaccines Are Not Behind the Rise in Autism. So What Is?
There is no one factor that causes autism — or explains its growing prevalence. Researchers are seeking explanations for the…
RFK Jr., Rejecting Vaccine Data, Fuels Distrust of Public Health Agencies
By promoting suspicions about the institutions he oversees, critics say Robert F. Kennedy Jr. is jeopardizing public health. He says…